Tag: Cronos
Cronos Group invests $110.4 million, takes 10.5% ownership PharmaCann
June 14, 2021
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group”) and PharmaCann Inc. (“PharmaCann”), one of…
Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG
June 4, 2021
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group”), an innovative global cannabinoid company, and Ginkgo Bioworks,…
Cronos Group Reports 2021 First Quarter Results
May 7, 2021
Receives processing license for the commercial production and sale of cannabinoids using biosynthesis Announces plans…
Kristen Bell’s Happy Dance Available Now at Ulta Beauty
March 15, 2021
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that the…
Cronos Group Reports 2020 Fourth Quarter and Full-Year Results
February 26, 2021
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), today announces its 2020 fourth…
Recent Comments